669
Participants
Start Date
April 30, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
August 31, 2026
Rcombinant botulinum toxin type A for injection(Eveotox)
Rcombinant botulinum toxin type A for injection(Eveotox)
OnabotulinumtoxinA (Botox)
OnabotulinumtoxinA (Botox)
Placebo
Placebo
RECRUITING
Peking Union Medical College Hospital, Beijing
RECRUITING
Peking University First Hospital, Beijing
RECRUITING
Peking University Third Hospital, Beijing
RECRUITING
The First Affiliated Hospital of Chongqing Medical University, Chongqing
RECRUITING
The First Affiliated Hospital of Jinan University, Guangzhou
RECRUITING
The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou
RECRUITING
The First Hospital of Hebei Medical University, Shijiazhuang
RECRUITING
The Third Xiangya Hospital of Central South University, Changsha
RECRUITING
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
RECRUITING
Huashan Hospital, Fudan University, Shanghai
RECRUITING
Xianyang Hospital of Yan'an University, Xianyang
RECRUITING
West China Hospital, Sichuan University, Chengdu
RECRUITING
Tianjin Medical University General Hospital, Tianjin
RECRUITING
Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou
RECRUITING
Zhejiang Provincial People's Hospital, Hangzhou
JHM BioPharma (Tonghua) Co. , Ltd.
NETWORK